Erythrocyte and brain methionine adenosyltransferase activities in patients with schizophrenia

Journal of Neural Transmission

Volumn 105, Issue 10-12, 1998, Pages 1293-1305

  Gomes Trolin, C ^a   Yassin, M ^b   Gottfries, C G ^b   Regland, B ^b   Grenfeldt, B ^b   Hallman, J ^b   Prince, J ^b   Oreland, L ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

Erythrocytes; Human brain; Methionine adenosyltransferase; Neuroleptics; Rat brain; Schizophrenia

Indexed keywords

METHIONINE ADENOSYLTRANSFERASE; NEUROLEPTIC AGENT;

ADULT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME MECHANISM; ERYTHROCYTE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; THALAMUS;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; ERYTHROCYTES; FEMALE; HUMANS; MALE; METHIONINE ADENOSYLTRANSFERASE; MIDDLE AGED; POSTMORTEM CHANGES; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 0032416523     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050132     Document Type: Article

References (51)

1. Agnoli A, Andreoli VM, Casacchia M, Maffei F, Fazio C (1976) In: Andreoli VM, Agnolli A, Fazio C (eds) Transmethylations and the central nervous system. Springer, Berlin Heidelberg New York, pp 170-182
2. Alarcon RD, Tolbert LC, Monti JA, Morere DA, Walter-Ryan WG, Kemp B, Smythies JR (1985) One-carbon metabolism disturbances in affective disorders. J Affect Disord 9: 297-301
3. Andreoli VM, Maffei F, Tonon GC (1976) S-adenosylmethionine (SAMe) blood levels in schizophrenia and depression. In: Andreoli VM, Agnolli A, Fazio C (eds) Transmethylations and the central nervous system. Springer, Berlin Heidelberg New York, pp 147-150
4. Baldessarini RJ (1987) Neuropharmacology of S-adenosylmethionine. Am J Med 83 [Suppl 5A]: 95-103
5. Bell KM, Potkin SG, Carreon D, Plon L (1994) S-adenosylmethionine blood levels in depressive phase: changes with drug treatment. Acta Neurol Scand 89 [Suppl 154]: 15-18
6. Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel F-A (1985) Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenia patients and healthy controls. Br J Psychiatry 147: 276-282
7. Bottiglieri T, Hyland K (1994) S-adenosylmethionine levels in psychiatric and neurological disorders: a review. Acta Neurol Scand 89 [Suppl 154]: 19-26
8. Bottiglieri T, Chary TK, Laundy M, Carney MWP, Godfrey P, Toone BK, Reynolds EH (1988) Transmethylation in depression. Alabama J Med Sci 25: 296-301
9. Bottiglieri T, Godfrey P, Flynn T, Carney MWP, Toone BK, Reynolds EH (1990) Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 53: 1096-1098
10. Bottiglieri T, Hyland K, Reynolds EH (1994) The clinical potential of ademethionine (S-adenosylmethionine) in neurological disorders. Drugs 48: 137-152
11. Bracken P, Coll P (1985) Homocystinuria and schizophrenia. Literature review and case report. J Nerv Ment Dis 173: 51-55
12. Bressa GM (1994) S-adenosyl-L-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand 89 [Suppl 154]: 7-14
13. Cantoni GL (1953) S-adenosylmethionine: a new intermediate formed enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem 204: 402-416
14. Cantoni GJ, Durell J (1957) Activation of methionine for transmethylation. II. The methionine activating enzyme: studies on the mechanism of the reaction. J Biol Chem 225: 1033-1048
15. Carl GF, Crews EL, Carmichael SM, Benesh FC, Smythies JR (1978) Four enzymes of one-carbon cycle metabolism in blood cell ot schizophrenics. Biol Psychiatry 13: 773-776
16. Cheng H, Gomes-Trolin C, Aquilonius SM, Steinberg A, Lofberg C, Ekblom J, Oreland L (1997) Levels of L-methionine S-adeenosyltransferase in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp Neurol 145: 580-585
17. Clarke S (1985) Protein carboxyl methyltransferases: two distinct classes of enzymes. Ann Rev Biochem 54: 479-506
18. Cohen BM, Lipinski JF, Vuckovic A, Prosser E (1982) Blood S-adenosylmethionine levels in psychiatric disorders. Am J Psychiatry 139: 229-231
19. Cundy KC, Sato M, Crooks PA (1985) Stereospecific in vivo N-methylation of nicotine in the guinea pig. Drug Metab Dispos 13: 175-185
20. Friedel HA, Goa KL, Benfield P (1989) S-Adenosylmethionine: a review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 38: 389-416
21. Gomes-Trolin C, Ekblom J, Oreland L (1998) Regulation of Methionine Adenosyltransferase catalytic activity and messenger RNA in SH-SY5Y human neuroblastima cells. Biochem Pharmacol 55: 567-571
22. Gomes-Trolin C, Löfberg C, Trolin G, Oreland L (1994) Brain ATP:L-methionine S-adenosyltransferase (MAT). S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH): regional distribution and age-related changes. Eur Neuropsychopharmacol 4: 469-477
23. Gomes-Trolin C, Regland B, Oreland L (1995) Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders. Eur Neuropsychopharmacol 5: 107-114
24. 12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type. J Neural Transm 103: 861-872
25. Greene, RC (1969) Kinetic studies of the mechanisms of S-adenosylmethionine synthetase from yeast. Biochem 8: 2255-2265
26. Ismail L, Sargent T, Dobson EL, Pollycove M (1978) Altered metabolism of the methionine methyl group in the leukocytes of patients with schizophrenia. Biol Psychiatry 13: 649-660
27. Israelstam DM, Sargent T, Finley NN, Winchell HS, Fish MB, Motto J, Pollycove M, Johnson A (1970) Abnormal methionine metabolism in schizophrenic and depressive states: a preliminary report. J Psychiatry Res 7: 185-190
28. Jacobsen SJ, Hoffman RM, Erbe RW (1980) Regulation of methionine adenosyltransferase in normal diploid and simian virus 40-transformed human fibroblasts. J Natl Can Inst 65: 1237-1244
29. Kelsoe JR, Tolbert LC, Crews EL, Smythies JR (1982) Kinetic evidence for decreased methionine adenosyltransferase activity in erythrocytes from schizophrenics. J Neurosci Res 8: 99-103
30. Kotb M, Geller AM (1993) Methionine adenosyltransferase: structure and function. Pharmacol Ther 59: 125-143
31. Langkamp-Henken B, Geller AM, LeGross HL, Price JO, De La Rosa J, Kotb M (1994) Characterization of distinct forms of methionine adenosyltransferase in nucleated, and mature human erythrocytes and erythroleukemic cells. Biochim Biophys Acta 1201: 397-404
32. Maeda N, Kon K, Sekiya M, Shiga T (1986) Increase of ATP level in human erythrocytes induced by S-adenosylmethionine. Biochem Pharmacol 35: 625-629
33. Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206-210
34. Mathysse S, Baldessarini RJ (1972) S-adenosylmethionine and catechol-O-methyltransferase in schizophrenia. Am J Psychiatry 128: 1310-1312
35. Montera C, Smolenski RT, Duley JA, Simmonds HA (1990) S-adenosylmethioninen increase erythrocyte ATP in vitro by a route independent of adenosine kinase. Biochem Pharmacol 40: 2617-2623
36. Morere DA, Alarcon RD, Monti JA, Walter-Ryan WG, Bancroft AJ, Symthies JR, Tolbert LC (1986) Medication effects on one-carbon metabolism in schizophrenia, mania, and depressive phase. J Clin Psychopharmacol 6: 155-161
37. Oden KL, Clarke S (1983) S-adenosyl-L-methionine synthetase from human erythrocytes: role in the regulation of cellular S-adenoysl methionine levels. Biochem 22: 1978-1986
38. Pakkenberg B (1987) Post-mortem study of schizophrenic brains. Br J Psychiatry 151: 744-752
39. Pardridge WM (1977) Regulation of amino acid availability to the brain. In: Wurtman RJ, Wurtman JJ (eds) Nutrition and the brain, vol 1. Raven Press, New York, pp 142-204
40. Regland B, Johansson BV, Gottfries C-G (1994) Homocysteinemia and schizophrenia as a case of methylation deficiency. J Neural Transm [Gen Sect] 98: 143-152
41. Rubin RA, Ordonez LA, Wurtman RJ (1974) Physiological dependence of brain methionine and S-adenosylmethionine concentrations on serum amino acid pattern. J Neurochem 23: 245-258
42. Sargent T 3rd, Kusubov N, Taylor SE, Budinger TF (1992) Tracer kinetic evidence for abnormal methyl metabolism in schizophrenia. Biol Psychiatry 32: 1078-1090
43. Sherif F, Gomes C, Oreland L (1993) Methionine synthase and methionine adenosyltransferase activities in rat brain after ethanol treatment. Pharmacol Toxicol 73: 287-290
44. Simmonds HA, Fairbanks LD, Duley JA, Morris GS (1989) ATP formation from deoxyadenosine in human erythrocytes: evidence for a hitherto unidentified route involving adenine and S-adenosylhomocysteine hydrolase. Biosci Reports 9: 75-85
45. Smythies JR (1984) The transmethylation hypothesis of schizophrenia re-evaluated. Trends Neurosci (TINS) 7: 45-47
46. Smythies JR, Alarcon RD, Morere D, Monti JA, Steele M, Tolbert LC, Walter-Ryan, WG (1986) Abnormalities of one-carbon metabolism in psychiatric disorders: study of methionine adenosyltransferase kinetics and lipid composition of erythrocyte membranes. Biol Psychiatry 21: 1391-1398
47. Tolbert LC (1988) A new treatment for depression: S-adenosylmethionine. Alabama J Med Sci 25: 291-296
48. Volpe JJ, Laster L (1970) Trans-sulphuration in primate brain: regional distribution of methionine-activating enzyme in the brain of the rhesus monkey at various stages of development. J Neurochem 17: 413-437
49. Waldmeyer PC, Feldtrauer JJ (1987) On the role of O-methylation in the metabolism of S-adeenosylmethionine in rat brain. Biochem Pharmacol 36: 2855-2861
50. Weinberger DR (1995) Neurodevlopmental perspectives on schizophrenia. In: Bloom FE, Kupfer FDJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1171-1183
51. Winn P (1994) Schizophrenia research moves to the prefrontal cortex. Trends Neurosci 17: 265-268